IP Library › Assignment 040105/0813
Patent Assignment
Reel/Frame 040105/0813

Assignment of Assignor's Interest

Recorded: 2016-10-24 Pages: 2
Assignor
RESVERLOGIX CORP.
Executed: 2013-03-01
Assignee
RVX THERAPEUTICS INC.
202,279 MIDPARK WAY SE, CALGARY, AB, T2X 1M2, CANADA
Covered Property (1)
Novel Heterocyclic Compounds as Bromodomain Inhibitors
Patent: 9,598,367 →
Application: 14/997,213 →
Publication: US 2016/0130228
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 24, 2016
From: LIU, SHUANG; DUFFY, BRYAN CORDELL; JIANG, MAY XIAOWU; WANG, RUIFANG
To: RESVERLOGIX CORP.
Reel/Frame 040105/0799 →
General Conveyance and Assumption Agreement Oct 24, 2016
From: RVX THERAPEUTICS INC.
To: ZENITH EPIGENETICS CORP.
Reel/Frame 040264/0102 →
Change of Name Dec 21, 2016
From: ZENITH EPIGENETICS CORP.
To: ZENITH CAPITAL CORP.
Reel/Frame 041120/0548 →
Assignment of Assignor's Interest Dec 23, 2016
From: ZENITH CAPITAL CORP.
To: ZENITH EPIGENETICS LTD.
Reel/Frame 041182/0891 →